The metabotropic glutamate receptors: potential drug targets for the treatment of anxiety disorders?

European Journal of Pharmacology
Nikolaos Pitsikas

Abstract

Anxiety-related disorders are a common public health issue. Several lines of evidence suggest that altered glutamatergic neurotransmission underlies anxiety. Thus, novel molecules targeting glutamatergic neurotransmission, such as ligands of the metabotropic glutamate receptors (mGlurs) might be promising candidates for the treatment of anxiety disorders. To date, several ligands selective for each mGlu receptor (mGlur) have been synthesized, and pharmacological significances of these compounds have been demonstrated mainly in animal models. Here we critically review advances in research of these emerging molecular targets for the treatment of anxiety, discuss their advantages over currently used anxiolytics as well as remaining challenges.

References

Dec 1, 1983·Neuropharmacology·M E GoldbergJ B Malick
Jan 1, 1997·Annual Review of Pharmacology and Toxicology·P J Conn, J P Pin
May 29, 2003·Current Drug Targets. CNS and Neurological Disorders·Laura E Chavez-NoriegaUna C Campbell
May 29, 2003·Current Drug Targets. CNS and Neurological Disorders·Darryle D Schoepp DD, Gerard J Marek
Aug 21, 2003·Progress in Neurobiology·Mark J Millan
Mar 17, 2004·Current Opinion in Pharmacology·Gerard J Marek
Aug 12, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Chris S BusseNicholas D P Cosford
Jan 25, 2005·Nature Reviews. Drug Discovery·Chad J SwansonDarryle D Schoepp
Sep 30, 2005·International Clinical Psychopharmacology·Veerle Bergink, Herman G M Westenberg
Jun 22, 2007·Pharmacology & Therapeutics·Agnieszka Palucha, Andrzej Pilc
Aug 23, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Eduardo DunayevichGary D Tollefson
May 10, 2008·Nature Reviews. Neuroscience·Paulo S Pinheiro, Christophe Mulle
May 12, 2009·Neurochemistry International·Joanna M Wierońska, Andrzej Pilc
Nov 3, 2010·Neuropharmacology·F NicolettiJ P Pin
May 7, 2011·British Journal of Pharmacology·John F Cryan, Fabian F Sweeney
Mar 26, 2013·Neurodegenerative Disease Management·Jonathan W Dickerson, P Jeffrey Conn

❮ Previous
Next ❯

Citations

Apr 10, 2014·Biological Trace Element Research·Eluza Curte Stangherlin, Cristina Wayne Nogueira
Aug 12, 2015·Pharmacology, Biochemistry, and Behavior·Ricieri MocelinAngelo L Piato
Jun 23, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Maria Domenica SannaLucia Morbidelli
May 27, 2016·Sleep Science·Ana Carolina D NosedaMarcelo M S Lima
Jul 16, 2014·Bioorganic & Medicinal Chemistry Letters·Katalin NógrádiZsolt Szombathelyi
Apr 16, 2015·TheScientificWorldJournal·Takeshi FuchigamiSakura Yoshida
May 11, 2016·European Journal of Pharmacology·Jie DuYuan-Jian Li
Oct 18, 2018·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Patrícia SantosAngelo Piato
Jan 9, 2018·Royal Society Open Science·Marie-Jeanne Perrot-MinnotFrank Cézilly
Oct 30, 2019·Current Topics in Medicinal Chemistry·Pedro de Sena M PinheiroCarlos A M Fraga
Nov 27, 2019·Naunyn-Schmiedeberg's Archives of Pharmacology·Carlos G ReisAngelo Piato
Sep 21, 2019·Annual Review of Pharmacology and Toxicology·Davide Calebiro, Jak Grimes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.